- JP-listed companies
- Fuso Pharmaceutical Industries,Ltd.
- Financials
- Operating margin (%)
Fuso Pharmaceutical Industries,Ltd. (4538)
Market cap
¥21.8B
P/E ratio
8.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
| Period End | Operating margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 6.8 | +92.43% |
| Mar 31, 2024 | 3.5 | -18.03% |
| Mar 31, 2023 | 4.3 | +11.55% |
| Mar 31, 2022 | 3.9 | -18.79% |
| Mar 31, 2021 | 4.8 | +121.67% |
| Mar 31, 2020 | 2.2 | -21.32% |
| Mar 31, 2019 | 2.7 | +57.42% |
| Mar 31, 2018 | 1.7 | +23.98% |
| Mar 31, 2017 | 1.4 | +116.74% |
| Mar 31, 2016 | 0.6 | -61.77% |
| Mar 31, 2015 | 1.7 |